Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy
-
- Hironobu Yanagie
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Novriana Dewi
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Syushi Higashi
- Department of Surgery, Kojinkai Medical City East Hospital, Miyazaki, Japan
-
- Ichiro Ikushima
- Department of Radiology, Miyakonojyo Metropolitan Hospital, Miyazaki, Japan
-
- Koji Seguchi
- Department of Surgery, Kojinkai Medical City East Hospital, Miyazaki, Japan
-
- Ryoji Mizumachi
- Department of Pharmacology, Kumamoto Institute Branch, LSI Medience Co. Ltd, Kumamoto, Japan
-
- Yuji Murata
- Department of Pharmacology, Kumamoto Institute Branch, LSI Medience Co. Ltd, Kumamoto, Japan
-
- Yasuyuki Morishita
- Department of Human and Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
-
- Atsuko Shinohara
- Department of Humanities, The Graduate School of Seisen University, Tokyo, Japan
-
- Shoji Mikado
- Department of Physics, College of Industrial Technology, Nihon University, Chiba, Japan
-
- Nakahiro Yasuda
- Research Institute of Nuclear Engineering, University of Fukui, Fukui, Japan
-
- Mitsuteru Fujihara
- SPG Technology Co. Ltd, Miyazaki, Japan
-
- Yuriko Sakurai
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Kikue Mouri
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Masashi Yanagawa
- Veterinary Medical Center, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan
-
- Tomoya Iizuka
- Department of Veterinary Surgery, The University of Tokyo Veterinary Hospital, Tokyo, Japan
-
- Minoru Suzuki
- Research Reactor Institute, Kyoto University, Osaka, Japan
-
- Yoshinori Sakurai
- Research Reactor Institute, Kyoto University, Osaka, Japan
-
- Shin-ichiro Masunaga
- Research Reactor Institute, Kyoto University, Osaka, Japan
-
- Hiroki Tanaka
- Research Reactor Institute, Kyoto University, Osaka, Japan
-
- Takehisa Matsukawa
- Department of Epidemiology and Environmental Health, Juntendo University Graduate School of Medicine, Tokyo, Japan
-
- Kazuhito Yokoyama
- Department of Epidemiology and Environmental Health, Juntendo University Graduate School of Medicine, Tokyo, Japan
-
- Takashi Fujino
- Department of Pathological Diagnosis, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan
-
- Koichi Ogura
- Department of Physics, College of Industrial Technology, Nihon University, Chiba, Japan
-
- Yasumasa Nonaka
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Hirotaka Sugiyama
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Tetsuya Kajiyama
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Sho Yui
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Ryohei Nishimura
- Department of Veterinary Surgery, The University of Tokyo Veterinary Hospital, Tokyo, Japan
-
- Koji Ono
- Research Reactor Institute, Kyoto University, Osaka, Japan
-
- Sinichi Takamoto
- Department of Cardiac Surgery, Mitsui Memorial Hospital, Tokyo, Japan
-
- Jun Nakajima
- Cooperative Unit of Medicine and Engineering, The University of Tokyo Hospital, Tokyo, Japan
-
- Minoru Ono
- Cooperative Unit of Medicine and Engineering, The University of Tokyo Hospital, Tokyo, Japan
-
- Masazumi Eriguchi
- Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
-
- Kenichiro Hasumi
- Hasumi International Research Foundation, Tokyo, Japan
-
- Hiroyuki Takahashi
- Department of Nuclear Engineering and Management, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan
収録刊行物
-
- The British Journal of Radiology
-
The British Journal of Radiology 90 (1074), 20170004-, 2017-06
Oxford University Press (OUP)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360565169111033984
-
- ISSN
- 1748880X
- 00071285
-
- データソース種別
-
- Crossref
- KAKEN